Haemoseis 256 - Scalene South Africa | Green Energy | Cybernetics

Search
Go to content

Main menu

Haemoseis 256

Overview

Haemosis 3d vasculography is a revolutionary non-invasive technigue for early identification and management of life threatening cardiovasscular diseases. It provides a detailed analysis of cardiovascular haemodynamics, electrodynamics and pulmony pathology, by providing more than sixty vital cardiovascular parameters including systematic and cardiac blood flows and many more to identify and characterize global haemodynamic patterns which are consistent with Coronary Artery Disease and other circulatory disorders.

With a complete vital haemodynamic picture of the heart, lungs, and blood vessels, Haemosis - 256 brings you new and powerful cardiovascular information to the out- patient clinic, emergency room, intensive care units, cath labs and operation theatres.

Haemosis provides unigue details of minute deiation on flow patterns, invaluable for acxcurate monitoring of cardiac functions. Haemosis 3d vasculography scan is a risk free, accurate and cost effective assessment of cardiovascular functions that aids in clinical evaluation, general, health screening, monitoring of therapy and medical research. It empowers the doctors with more and unigue information of the cardiovascular system, never before possilble non-invasively.


Technology

Haemosis 3d vasculography uses advanced patented technologies od trans - Aortic signal wave modulation (TASWM) and flow Turbulence Accelerometry (FTA) to measure and record minute changes in the cardiovascular system every millonth of a second and provides more than sixty vital cardiovascular functional variables, which directly aid the doctor in making decisions not only in cardiac care but also in other areas of medical practise. 3d vasculgraphy brings advanced techniques to simulation, neural networks and dynamic fluid mechanicss : parameters used in space technology, to conviently get a comprehensive functional status of the circulatory system that can be used for cardiovascular diagnosis, management and prognosis. The procedure is 3 dimensional vasculography scan.



Who will benefit from 3D Vasculography?
Symptomatic patients above 30 years of age.
Asymptomatic patients above 35 years of age who want to know their risk status.

High risk patients with a strong family history of:
             * Coronary artery disease (CAD)
             * High blood pressure
             * Diabetes

People who are highly stressed or overweight.
People who need optimization of medication.
People who are unable or do not wish to go for invasive diagnostic procedures.
Patients who require a second opinion before going for coronary artery bypass surgery.

People who perform physically demanding jobs such as pilots, police, navy & military personnel.

Corporate companies needing to assess the health status of their key personnel.


Advantages

Haemosis 3d vasculography is the only technology that can give more than 60 vitalcardoivascular parameters; several of them were never before possible non-invasively. The easily understandable graphical presentation of most sought information for early detection leading to early intervention thus aiding in primary prevention of cardiovascular disorders some of wich are represented below.



How is 3D Vasculography testing done
and how long does it take?

The duration of the test is between 30 to 45 minutes. The patient lies flat on a bed and a system of signal generating and signal receiving electrodes that are attached to cables are strategically placed on the patient's body, together with a highly sensitive Vertical Acceleration Device (VAD). Blood pressure is measured continuously during the test. Trans-Aortic Signal Wave Modulation (TASWM) and Flow Turbulence Accelometry (FTA) are used to reconstruct and transmit over sixty 3 Dimensional real time images and measures. The 23 page data is printed and interpreted before a complete summary report is compiled.


Clinical Applications

Reliable detection of coronary artery disease and its severity.

Early detection of coronary artery disease in asymptomatic patients.

Establish proneness to sudden cardiac death syndrome (SCDS).

Establish cause of chest pains in undiagnosed cardiac patients.

In critical care medicine-for monitoring vital functions non-invasively and drug use to improve  prognosis optimizing.

Establishment of fluid overload during dialysis, plasmapheresis.

Early detection of pulmonary oedema, before the development of clinical symptoms.

Establishment of functional effectiveness of drugs and treatment.

Can be used effectively before, during and after procedures like External Counterpulsation (ECP) or Intra-Aortic Balloon Pump (IABP), where measurement of coronary perfusion pressure, coronary blood flow and valvular pliability is important.

An invaluable tool in evaluating the degree of success of Angioplasty, Coronary Artery Stent insertion, Coronary Artery Bypass Grafting (CABG) and Valve Repair surgery.


Approvals & Endorsements
There are currently 150 machines in 20 countries across the world.
The 3D Vasculography device has CE approval which is recognised internationally.

Back to content | Back to main menu